JASON P. HAFLER

Jason P. Hafler is a distinguished Managing Director at Sanofi Ventures, where he plays a pivotal role in identifying and nurturing the next generation of life science and healthcare innovators. As part of Sanofi's dedicated corporate venture capital fund, Mr. Hafler is instrumental in driving strategic investments that align with Sanofi's broader therapeutic and technological interests. His expertise spans a wide array of areas, including novel therapeutics, cutting-edge digital health solutions, and advanced medical devices, all aimed at addressing significant unmet medical needs.

Mr. Hafler joined Sanofi Ventures in 2015, bringing a wealth of experience from both the pharmaceutical industry and investment banking. Prior to his tenure at Sanofi Ventures, he held a key position in Corporate Strategy & Business Development at Regeneron Pharmaceuticals. This experience provided him with deep insights into the operational and strategic challenges faced by biopharmaceutical companies, from drug discovery and development to commercialization. Before his time at Regeneron, Mr. Hafler honed his financial acumen in investment banking at Lazard Freres & Co., where he advised clients on mergers, acquisitions, and other strategic transactions within the healthcare sector. This diverse background equips him with a unique perspective, blending financial rigor with a profound understanding of scientific innovation and market dynamics.

At Sanofi Ventures, Jason P. Hafler's investment focus is broad yet strategic, targeting companies that are developing transformative solutions. He is particularly interested in areas such as oncology, immunology, rare diseases, and neuroscience, reflecting Sanofi's core therapeutic priorities. Beyond traditional therapeutics, he also actively seeks opportunities in digital health, recognizing its potential to revolutionize patient care, improve outcomes, and enhance healthcare delivery. His involvement extends from early-stage startups to more mature growth-stage companies, providing capital and strategic guidance to help these ventures scale and achieve their clinical and commercial milestones.

While specific individual investments are often a collaborative effort within Sanofi Ventures, Mr. Hafler has been a key contributor to the fund's impressive portfolio. Sanofi Ventures has invested in numerous innovative companies that are pushing the boundaries of medical science. Examples of the types of companies within the Sanofi Ventures portfolio, where Mr. Hafler's expertise contributes, include those developing novel gene therapies, precision medicines, and AI-driven diagnostic tools. His commitment to fostering innovation underscores Sanofi Ventures' mission to support companies that can bring meaningful advancements to patients worldwide, ultimately shaping the future of healthcare. His leadership helps ensure that Sanofi Ventures remains at the forefront of strategic life science investing.